Abstract:Objectives To quantify the frequency and clinical implications of systemic sclerosis (SSc)-associated left ventricular function (LV) impairment. Methods Australian Scleroderma Cohort Study participants meeting ACR/EULAR criteria for SSc with ≥1 echocardiographic LVEF measurement were included. Overt LV dysfunction was indicated by reduced LV ejection fraction (LVEF) and subclinical LV dysfunction was measured using impaired LV global longitudinal strain (LV-GLS>-16%). Those with secondary causes of LV dysfunction (myocardial ischaemia, valvulopathy and pulmonary arterial hypertension) were excluded. Chi-squared tests, two-sample t-tests or Wilcoxon rank-sum tests were used for between-group comparison as appropriate. Generalised estimating equations(GEE) were used to model longitudinal data. Kaplan-Meier and Cox proportional hazard models were used for survival analyses. Results Of 1141 participants with no co-morbid cardiac disease, 2.4% ever recorded a LVEF<50%, while only 0.6% ever recorded a LVEF≤40%. LV-GLS data were available for 90% of participants at one centre (n=218). Impaired LV-GLS was detected in 21% despite LVEF≥50%. Those with a LVEF<50% were more frequently male (p=0.01) with dcSSc (p<0.01), higher inflammatory markers (p<0.02) and skeletal muscle disease (p<0.05). In multivariable analyses, recording a LVEF<50% was associated with increased mortality (HR2.3, 95%CI1.0-4.8, p=0.04). Impaired LV-GLS was also associated with poorer survival in univariable analyses (HR3.4, 95%CI1.0-11.8, p=0.05). Those with a LVEF<50% more frequently recorded WHO Class III/IV dyspnoea (OR3.5, 95%CI1.6-7.7, p<0.01), with shorter six-minute walk distance (p=0.01), higher Health Assessment Questionnaire-Disability Index scores (p<0.01) and lower Short Form-36 Physical Component Summary scores (p=0.02). Increased dyspnoea (WHO Class III/IV dyspnoea; OR3.6, 95%CI1.4-9.2, p<0.01) was also seen in those with impaired LV-GLS. Conclusions Both overt and subclinical SSc-associated LV dysfunction are associated with worse survival and impaired physical function. The frequency of abnormal LV-GLS in those with consistently normal LVEF suggests an under-appreciated burden of subtle LV systolic dysfunction in SSc that has a significant impact on patient symptomatology.

Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study

Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study

Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study

Characteristics and predictors of sexual dysfunction in men with multiple sclerosis

Genital tract abnormalities and female sexual function impairment in systemic sclerosis

Lived Experiences of Sexuality and Sexual Functioning in Males with SCI: A Mixed-Methods Study

Factors associated with satisfaction with social roles and activities among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study

Systemic sclerosis and anorectal dysfunction: The Leeds experience

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis

Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis

Functional capacity, physical activity, and arterial stiffness in patients with systemic sclerosis

Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners

Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis

Assessment of fertility and sexual dysfunction in women with systemic sclerosis: a narrative review of the literature

The functional disabilities of the dominant and opposite hands in patients with systemic sclerosis

Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis

Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results

Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study

Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography

Disease specific determinants of cardiopulmonary fitness in systemic sclerosis